VGX Pharmaceuticals, LLC clinical trials
Acquired by Inovio Pharmaceuticals, Jun 1, 2009 · source ↗
The registry lists 4 studies whose lead sponsor is VGX Pharmaceuticals, LLC. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 9, 2010.
Before and after it joined Inovio Pharmaceuticals
- First submitted before VGX Pharmaceuticals, LLC became part of Inovio Pharmaceuticals
- 4
- First submitted after VGX Pharmaceuticals, LLC became part of Inovio Pharmaceuticals
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- VGX Pharmaceuticals, LLC4 studies
Something wrong with this grouping? Tell us on the Inovio Pharmaceuticals page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Inovio Pharmaceuticals studies →
- Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected SubjectsCompletedNCT00352911Phase 2
Sponsor listed in the registry: VGX Pharmaceuticals, LLC · First submitted before VGX Pharmaceuticals, LLC became part of Inovio Pharmaceuticals
- Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected PatientsCompletedNCT00255177Phase 2
Sponsor listed in the registry: VGX Pharmaceuticals, LLC · First submitted before VGX Pharmaceuticals, LLC became part of Inovio Pharmaceuticals
- Multiple-Dose Study of VGX-1027 in Healthy SubjectsCompletedNCT00760396Phase 1
Sponsor listed in the registry: VGX Pharmaceuticals, LLC · First submitted before VGX Pharmaceuticals, LLC became part of Inovio Pharmaceuticals
- Phase I Safety and Pharmacokinetic Study of VGX-1027 in Healthy SubjectsCompletedNCT00627120Phase 1
Sponsor listed in the registry: VGX Pharmaceuticals, LLC · First submitted before VGX Pharmaceuticals, LLC became part of Inovio Pharmaceuticals